Meryl Selig has had a unique Stanford journey. She began as a patient volunteer and then became a patient after being diagnosed with B-cell lymphoma. She underwent chemotherapy and enrolled in a clinical trial for a novel CAR-T cell treatment. Soon thereafter, Selig and her husband became donors, sponsoring promising new research like the therapy she was treated with. She sat down with the Stanford Cancer Institute team to share her transformative experience.

Learn more about our Cancer Clinical Trials, and ways to support our mission:
[ Ссылка ]
[ Ссылка ]
Learn more about the Stanford Cancer Institute: [ Ссылка ]

Follow the Stanford Cancer Institute
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Subscribe to the Stanford Cancer Institute: [ Ссылка ]

свернуть